Researchers have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
Click here for original story, Popular pharmaceutical target in cells may prove even more useful
Source: ScienceDaily